Related Experiment Video
Updated: Aug 16, 2026

A Modified Model Preparation for Middle Cerebral Artery Occlusion Reperfusion
Published on: May 31, 2024
MO.MA -- a new cerebral stroke protection system during carotid artery stenting
Dariusz Dudek1, Stanisław Bartuś, Tomasz Rakowski
1II Klinika Kardiologii Instytutu Kardiologii; Collegium Medicum, Uniwersytet Jagielloński, Kraków.
Insights
The MO.MA system effectively prevents stroke during carotid angioplasty and stenting (CAS). This novel cerebral protection device demonstrated safety and efficacy in a study of 21 patients undergoing CAS procedures.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Carotid angioplasty and stenting (CAS) is an alternative to carotid endarterectomy for carotid atherosclerosis.
- Cerebral protection devices are mandatory during CAS due to embolization risks.
Purpose of the Study:
- To evaluate the safety and efficacy of the MO.MA cerebral protection device.
- Assessing the MO.MA system's performance in patients undergoing CAS.
Main Methods:
- The study included 21 patients undergoing carotid stenting.
- Evaluated MO.MA system's deliverability, procedural success, and adverse event rates.
Main Results:
- All CAS procedures using the MO.MA system were successful.
- No major cerebrovascular complications occurred during 30-day and 6-month follow-ups.
Conclusions:
- The MO.MA system is a safe and effective tool for stroke prevention during CAS.
- The MO.MA system provides reliable cerebral protection in CAS procedures.
Background:
Carotid angioplasty and stenting (CAS) has been introduced as an alternative to carotid endarterectomy for the treatment of carotid atherosclerosis. Due to the risk of embolisation during CAS, the usage of cerebral protection devices is obligatory.
Aim:
To assess the safety and efficacy of the novel cerebral protection device -- the MO.MA system.
Methods:
Twenty one patients selected for carotid stenting were included into the study. We estimated the deliverability of the device to the target site, procedural success rate and the incidence of adverse events.
Results:
All performed procedures were successful without major cerebro-vascular complications during both 30-day and 6-month follow-up periods.
Conclusions:
The MO.MA system is safe and effective in preventing stroke during CAS.
Related Concept Videos
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
